Galmed Pharmaceuticals
GLMD
#11047
Rank
C$7.08 M
Marketcap
C$6.63
Share price
21.05%
Change (1 day)
402.30%
Change (1 year)

Earnings for Galmed Pharmaceuticals (GLMD)

Earnings in 2026 (TTM): -C$15.76 Million

According to Galmed Pharmaceuticals 's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -C$14.77 Million a decrease over its 2024 earnings that were of -C$10.77 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Galmed Pharmaceuticals from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$15.76 Million6.73%
2025 -C$14.77 Million37.14%
2024 -C$10.77 Million8.75%
2023 -C$9.9 Million-61.31%
2022 -C$25.59 Million-44.97%
2021 -C$46.5 Million12.85%
2020 -C$41.21 Million40.61%
2019 -C$29.31 Million109.19%
2018 -C$14.01 Million-20.47%
2017 -C$17.62 Million-27%
2016 -C$24.13 Million58.6%
2015 -C$15.22 Million16.7%
2014 -C$13.04 Million-47.94%
2013 -C$25.04 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Evoke Pharma
EVOK
-C$6.77 Million-58.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Endo International
ENDPQ
-C$3.43 Billion 20,987.19%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Aerie Pharmaceuticals
AERI
-C$33.29 Million 104.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalent
CTLT
-C$0.14 Billion 702.26%๐Ÿ‡บ๐Ÿ‡ธ USA